DPYD-CSNK1G1 Fusion FISH Probe
The DPYD-CSNK1G1 Fusion FISH Probe is used to confirm a fusion of the DPYD and CSNK1G1 genes. The fusion of the DPYD and CSNK1G1 genes has been associated with Ovarian Serous Cystadenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| DPYD-CSNK1G1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| DPYD-CSNK1G1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| DPYD-CSNK1G1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| DPYD-CSNK1G1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| DPYD-CSNK1G1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| DPYD-CSNK1G1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| DPYD-CSNK1G1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| DPYD-CSNK1G1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| DPYD-CSNK1G1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| DPYD-CSNK1G1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| DPYD-CSNK1G1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| DPYD-CSNK1G1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| DPYD-CSNK1G1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| DPYD-CSNK1G1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| DPYD-CSNK1G1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| DPYD-CSNK1G1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| DPYD-CSNK1G1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| DPYD-CSNK1G1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| DPYD-CSNK1G1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| DPYD-CSNK1G1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| DPYD-CSNK1G1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| DPYD-CSNK1G1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| DPYD-CSNK1G1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| DPYD-CSNK1G1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| DPYD-CSNK1G1-20-AQAQ | 20 (40 μL) | 200 μL |
|
DPYD Gene Summary
The protein encoded by this gene is a pyrimidine catabolic enzyme and the initial and rate-limiting factor in the pathway of uracil and thymidine catabolism. Mutations in this gene result in dihydropyrimidine dehydrogenase deficiency, an error in pyrimidine metabolism associated with thymine-uraciluria and an increased risk of toxicity in cancer patients receiving 5-fluorouracil chemotherapy. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2009]
Gene Name: Dihydropyrimidine Dehydrogenase
Chromosome: CHR1: 97543299 -98386615
Locus: 1p21.3
CSNK1G1 Gene Summary
This gene encodes a member of the casein kinase I gene family. This family is comprised of serine/threonine kinases that phosphorylate acidic proteins such as caseins. The encoded kinase plays a role in cell cycle checkpoint arrest in response to stalled replication forks by phosphorylating Claspin. A mutation in this gene may be associated with non-syndromic early-onset epilepsy (NSEOE). [provided by RefSeq, Jul 2016]
Gene Name: Casein Kinase 1 Gamma 1
Chromosome: CHR15: 64457715 -64648442
Locus: 15q22.31
Gene Diseases
The DPYD CSNK1G1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Ovarian Serous Cystadenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|